Sign In
NewsRadar

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S was established to manage the Foundation's funds and to invest actively in other companies. Furthermore Novo A/S has significant shareholdings in the publicly listed and independently operating companies Novo Nordisk A/S and Novozymes A/S.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Krogshøjvej 41
Bagsværd DK-2880
Denmark
+45 88 24 88 24
+45 88 24 88 20
http://www.novo.dk
Henrik Gürtler
+45 88 24 88 24

Company Facts
Type:
Capital managed:
Companies invested in:  
Investment managers:
Total staff size:
Number of offices:
Min. investment size:
Max. investment size:







Funding stages:
Geo. scope europe:
Investment distrib.:
Industry preferences:

Partners

Portfolio

Funds
NameStatusClosingSize
No Funds


Data


24,394
Tech investments
From our Online Data Service
15,775
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Jun 19€2.5MOther Biotechnology & Healthcare
Jun 19€5.0MMedical devices
Jun 19€13.0MInternet services
Jun 18€12.0MApplication integration
Jun 18€2.0MContent management
Jun 18€3.0MSecurity
Jun 8€68.0MWireless applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises 37.5 million in series a





About usContact usLegal Information
Copyright 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.